Cargando…

Respiratory involvement in ambulant and non-ambulant patients with facioscapulohumeral muscular dystrophy

Understand the occurrence and predictors of respiratory impairment in FSHD. Data from 100 FSHD patients was collected regarding demographics, genetics, respiratory status and pulmonary function tests, clinical manifestations and Clinical Severity Scale (CSS) scores. Patients were assigned to two sev...

Descripción completa

Detalles Bibliográficos
Autores principales: Moreira, Sandra, Wood, Libby, Smith, Debbie, Marini-Bettolo, Chiara, Guglieri, Michela, McMacken, Grace, Bailey, Geraldine, Mayhew, Anna, Muni-Lofra, Robert, Eglon, Gail, Williams, Maggie, Straub, Volker, Lochmüller, Hanns, Evangelista, Teresinha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5486574/
https://www.ncbi.nlm.nih.gov/pubmed/28550484
http://dx.doi.org/10.1007/s00415-017-8525-9
_version_ 1783246281404055552
author Moreira, Sandra
Wood, Libby
Smith, Debbie
Marini-Bettolo, Chiara
Guglieri, Michela
McMacken, Grace
Bailey, Geraldine
Mayhew, Anna
Muni-Lofra, Robert
Eglon, Gail
Williams, Maggie
Straub, Volker
Lochmüller, Hanns
Evangelista, Teresinha
author_facet Moreira, Sandra
Wood, Libby
Smith, Debbie
Marini-Bettolo, Chiara
Guglieri, Michela
McMacken, Grace
Bailey, Geraldine
Mayhew, Anna
Muni-Lofra, Robert
Eglon, Gail
Williams, Maggie
Straub, Volker
Lochmüller, Hanns
Evangelista, Teresinha
author_sort Moreira, Sandra
collection PubMed
description Understand the occurrence and predictors of respiratory impairment in FSHD. Data from 100 FSHD patients was collected regarding demographics, genetics, respiratory status and pulmonary function tests, clinical manifestations and Clinical Severity Scale (CSS) scores. Patients were assigned to two severity groups using CSS: mild (scores <3.5) and moderate/severely affected (scores ≥3.5). Forced Vital Capacity (FVC) was classified as severely impaired if less than 50% of the predicted. Statistical analysis was performed using IBM SPSS Statistics 23, tests were two-tailed and the level of significance set at 5%. Spirometry was available for 94 patients; 41.5% had abnormal results with a restrictive pattern in 38.3% patients. There was a correlation between FVC; CSS score and D4Z4 fragment length with a higher probability of severe respiratory involvement in the early onset group, moderate/severe disease and D4Z4 fragments <18 kb. Patients with severe respiratory involvement showed a high prevalence of sleep-disordered breathing. FVC decline over time was indicative of three progression groups. Respiratory involvement for both ambulant and non-ambulant patients with FSHD is more frequent and severe than previously suggested. Sleep-disordered breathing is frequent and negatively influences the respiratory status. Annual screening of the respiratory status with spirometry and clinical assessment is thus warranted in FSHD patients, even while ambulant. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00415-017-8525-9) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5486574
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-54865742017-07-17 Respiratory involvement in ambulant and non-ambulant patients with facioscapulohumeral muscular dystrophy Moreira, Sandra Wood, Libby Smith, Debbie Marini-Bettolo, Chiara Guglieri, Michela McMacken, Grace Bailey, Geraldine Mayhew, Anna Muni-Lofra, Robert Eglon, Gail Williams, Maggie Straub, Volker Lochmüller, Hanns Evangelista, Teresinha J Neurol Original Communication Understand the occurrence and predictors of respiratory impairment in FSHD. Data from 100 FSHD patients was collected regarding demographics, genetics, respiratory status and pulmonary function tests, clinical manifestations and Clinical Severity Scale (CSS) scores. Patients were assigned to two severity groups using CSS: mild (scores <3.5) and moderate/severely affected (scores ≥3.5). Forced Vital Capacity (FVC) was classified as severely impaired if less than 50% of the predicted. Statistical analysis was performed using IBM SPSS Statistics 23, tests were two-tailed and the level of significance set at 5%. Spirometry was available for 94 patients; 41.5% had abnormal results with a restrictive pattern in 38.3% patients. There was a correlation between FVC; CSS score and D4Z4 fragment length with a higher probability of severe respiratory involvement in the early onset group, moderate/severe disease and D4Z4 fragments <18 kb. Patients with severe respiratory involvement showed a high prevalence of sleep-disordered breathing. FVC decline over time was indicative of three progression groups. Respiratory involvement for both ambulant and non-ambulant patients with FSHD is more frequent and severe than previously suggested. Sleep-disordered breathing is frequent and negatively influences the respiratory status. Annual screening of the respiratory status with spirometry and clinical assessment is thus warranted in FSHD patients, even while ambulant. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00415-017-8525-9) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2017-05-26 2017 /pmc/articles/PMC5486574/ /pubmed/28550484 http://dx.doi.org/10.1007/s00415-017-8525-9 Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Communication
Moreira, Sandra
Wood, Libby
Smith, Debbie
Marini-Bettolo, Chiara
Guglieri, Michela
McMacken, Grace
Bailey, Geraldine
Mayhew, Anna
Muni-Lofra, Robert
Eglon, Gail
Williams, Maggie
Straub, Volker
Lochmüller, Hanns
Evangelista, Teresinha
Respiratory involvement in ambulant and non-ambulant patients with facioscapulohumeral muscular dystrophy
title Respiratory involvement in ambulant and non-ambulant patients with facioscapulohumeral muscular dystrophy
title_full Respiratory involvement in ambulant and non-ambulant patients with facioscapulohumeral muscular dystrophy
title_fullStr Respiratory involvement in ambulant and non-ambulant patients with facioscapulohumeral muscular dystrophy
title_full_unstemmed Respiratory involvement in ambulant and non-ambulant patients with facioscapulohumeral muscular dystrophy
title_short Respiratory involvement in ambulant and non-ambulant patients with facioscapulohumeral muscular dystrophy
title_sort respiratory involvement in ambulant and non-ambulant patients with facioscapulohumeral muscular dystrophy
topic Original Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5486574/
https://www.ncbi.nlm.nih.gov/pubmed/28550484
http://dx.doi.org/10.1007/s00415-017-8525-9
work_keys_str_mv AT moreirasandra respiratoryinvolvementinambulantandnonambulantpatientswithfacioscapulohumeralmusculardystrophy
AT woodlibby respiratoryinvolvementinambulantandnonambulantpatientswithfacioscapulohumeralmusculardystrophy
AT smithdebbie respiratoryinvolvementinambulantandnonambulantpatientswithfacioscapulohumeralmusculardystrophy
AT marinibettolochiara respiratoryinvolvementinambulantandnonambulantpatientswithfacioscapulohumeralmusculardystrophy
AT guglierimichela respiratoryinvolvementinambulantandnonambulantpatientswithfacioscapulohumeralmusculardystrophy
AT mcmackengrace respiratoryinvolvementinambulantandnonambulantpatientswithfacioscapulohumeralmusculardystrophy
AT baileygeraldine respiratoryinvolvementinambulantandnonambulantpatientswithfacioscapulohumeralmusculardystrophy
AT mayhewanna respiratoryinvolvementinambulantandnonambulantpatientswithfacioscapulohumeralmusculardystrophy
AT munilofrarobert respiratoryinvolvementinambulantandnonambulantpatientswithfacioscapulohumeralmusculardystrophy
AT eglongail respiratoryinvolvementinambulantandnonambulantpatientswithfacioscapulohumeralmusculardystrophy
AT williamsmaggie respiratoryinvolvementinambulantandnonambulantpatientswithfacioscapulohumeralmusculardystrophy
AT straubvolker respiratoryinvolvementinambulantandnonambulantpatientswithfacioscapulohumeralmusculardystrophy
AT lochmullerhanns respiratoryinvolvementinambulantandnonambulantpatientswithfacioscapulohumeralmusculardystrophy
AT evangelistateresinha respiratoryinvolvementinambulantandnonambulantpatientswithfacioscapulohumeralmusculardystrophy